Burrell Reagents LLC

Burrell Reagents LLC is engaged in the production and supply of high-quality chemical research reagents and laboratory products for scientific and industrial applications, primarily serving clients in North America. Burrell Reagents LLC was founded in 1969 and is headquartered in Belmont, US. The company specializes in providing research reagents and has pivoted its business strategy towards enhancing service quality in chemical supplies. The firm has completed three deals, with the most recent deal occurring on March 25, 2025.

Details about the company's founders or any previous companies they may have founded were not disclosed. Burrell Reagents specializes in the production and supply of high-quality chemical research reagents, laboratory products, and safety data sheets tailored for various applications in scientific research and industrial processes. Their core offerings include a comprehensive range of synthesized chemical compounds and reagents utilized in multiple sectors including pharmaceuticals, biotechnology, and environmental science. The company emphasizes providing lot-specific Certificates of Analysis (CoA) to ensure the reliability and traceability of their products, which are essential for laboratories and research institutions.

Reagents primarily serves a diverse clientele, including academic institutions, industrial researchers, and pharmaceutical companies across North America, specifically targeting markets in the United States and Canada. By integrating advanced chemical solutions into their product line, Reagents positions itself as a reliable partner in streamlining research and production processes. Reagents generates revenue through direct sales of its chemical products to commercial users and research institutions, emphasizing a business-to-business (B2B) transaction structure. Clients typically place orders based on specific product codes and lot numbers to ensure they receive the exact reagents required for their applications.

Transactions may include bulk orders for continual supply or one-time purchases for specific research projects, facilitating flexible pricing arrangements based on order size and product type. While specific pricing details for the products and services are not disclosed, it is understood that the firm maintains competitive pricing strategies to cater to its diverse client base. The company’s revenue model is supported by ongoing relationships with its customers, built on trust and the reliability of its high-quality offerings, which include proprietary formulations tailored to meet the specific demands of the research community. In March 2025, Audax Strategic Capital, along with other unspecified investors, invested in Burrell Reagents LLC, although the financial terms of the transaction were not disclosed.

The investment will allow Burrell Reagents LLC to enhance its services and strengthen its market presence in the specialty chemicals sector. The company is focused on launching new products designed to meet the evolving needs of its clients and expanding its reach into new markets, which may include international regions beyond its current North American focus.